Studies show that the extent of intestine resection in SBS patients directly correlates with loss of insulin sensitivity, impaired intestinal barrier function, low grade inflammation, and lipid accumulation. The gene discussed is INS; the disease is macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.